Skip to contentS
Selectis Health, Inc.
S
GBCSSelectis Health, Inc. Q2 2025 · 10-Q
Revenue$10.44M$10.44M+8.9% vs Q2 2024 Net Income-$308.03K-$308.03KN/M vs Q2 2024 EPS Diluted-$0.10-$0.10N/M vs Q2 2024 Operating Income-$450,289N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Selectis Health, Inc. · CIK 727346 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$240,894N/M Margins · derivedOperating margin-4.3%+3.7 pt vs Q2 2024
Net margin-3.0%−11.2 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 14, 2025 · 45 d after period end